Global Alirocumab Market Research Report 2024

Report ID: 1893704 | Published Date: Nov 2024 | No. of Page: 121 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
1 Alirocumab Market Overview
    1.1 Product Overview and Scope of Alirocumab
    1.2 Alirocumab Segment by Type
        1.2.1 Global Alirocumab Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Patent
        1.2.3 Generic
    1.3 Alirocumab Segment by Application
        1.3.1 Global Alirocumab Sales Comparison by Application: (2022-2028)
        1.3.2 Biochemical Reagents
        1.3.3 Pharmaceutical Intermediates
    1.4 Global Alirocumab Market Size Estimates and Forecasts
        1.4.1 Global Alirocumab Revenue 2017-2028
        1.4.2 Global Alirocumab Sales 2017-2028
        1.4.3 Alirocumab Market Size by Region: 2017 Versus 2021 Versus 2028
2 Alirocumab Market Competition by Manufacturers
    2.1 Global Alirocumab Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Alirocumab Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Alirocumab Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Alirocumab Manufacturing Sites, Area Served, Product Type
    2.5 Alirocumab Market Competitive Situation and Trends
        2.5.1 Alirocumab Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Alirocumab Players Market Share by Revenue
        2.5.3 Global Alirocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alirocumab Retrospective Market Scenario by Region
    3.1 Global Alirocumab Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Alirocumab Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Alirocumab Market Facts & Figures by Country
        3.3.1 North America Alirocumab Sales by Country
        3.3.2 North America Alirocumab Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Alirocumab Market Facts & Figures by Country
        3.4.1 Europe Alirocumab Sales by Country
        3.4.2 Europe Alirocumab Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Alirocumab Market Facts & Figures by Region
        3.5.1 Asia Pacific Alirocumab Sales by Region
        3.5.2 Asia Pacific Alirocumab Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Alirocumab Market Facts & Figures by Country
        3.6.1 Latin America Alirocumab Sales by Country
        3.6.2 Latin America Alirocumab Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Alirocumab Market Facts & Figures by Country
        3.7.1 Middle East and Africa Alirocumab Sales by Country
        3.7.2 Middle East and Africa Alirocumab Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Alirocumab Historic Market Analysis by Type
    4.1 Global Alirocumab Sales Market Share by Type (2017-2022)
    4.2 Global Alirocumab Revenue Market Share by Type (2017-2022)
    4.3 Global Alirocumab Price by Type (2017-2022)
5 Global Alirocumab Historic Market Analysis by Application
    5.1 Global Alirocumab Sales Market Share by Application (2017-2022)
    5.2 Global Alirocumab Revenue Market Share by Application (2017-2022)
    5.3 Global Alirocumab Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 AK Scientific
        6.1.1 AK Scientific Corporation Information
        6.1.2 AK Scientific Description and Business Overview
        6.1.3 AK Scientific Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 AK Scientific Alirocumab Product Portfolio
        6.1.5 AK Scientific Recent Developments/Updates
    6.2 Carbosynth
        6.2.1 Carbosynth Corporation Information
        6.2.2 Carbosynth Description and Business Overview
        6.2.3 Carbosynth Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Carbosynth Alirocumab Product Portfolio
        6.2.5 Carbosynth Recent Developments/Updates
    6.3 TargetMol Chemicals
        6.3.1 TargetMol Chemicals Corporation Information
        6.3.2 TargetMol Chemicals Description and Business Overview
        6.3.3 TargetMol Chemicals Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 TargetMol Chemicals Alirocumab Product Portfolio
        6.3.5 TargetMol Chemicals Recent Developments/Updates
    6.4 Beijing Aomi Jiade Pharmaceutical Technology
        6.4.1 Beijing Aomi Jiade Pharmaceutical Technology Corporation Information
        6.4.2 Beijing Aomi Jiade Pharmaceutical Technology Description and Business Overview
        6.4.3 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Portfolio
        6.4.5 Beijing Aomi Jiade Pharmaceutical Technology Recent Developments/Updates
    6.5 Hefei Hirisun Pharmatech
        6.5.1 Hefei Hirisun Pharmatech Corporation Information
        6.5.2 Hefei Hirisun Pharmatech Description and Business Overview
        6.5.3 Hefei Hirisun Pharmatech Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Hefei Hirisun Pharmatech Alirocumab Product Portfolio
        6.5.5 Hefei Hirisun Pharmatech Recent Developments/Updates
    6.6 Hubei Widely Chemical Technology
        6.6.1 Hubei Widely Chemical Technology Corporation Information
        6.6.2 Hubei Widely Chemical Technology Description and Business Overview
        6.6.3 Hubei Widely Chemical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Hubei Widely Chemical Technology Alirocumab Product Portfolio
        6.6.5 Hubei Widely Chemical Technology Recent Developments/Updates
    6.7 Hubei Xingcheng Biotechnology
        6.6.1 Hubei Xingcheng Biotechnology Corporation Information
        6.6.2 Hubei Xingcheng Biotechnology Description and Business Overview
        6.6.3 Hubei Xingcheng Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Hubei Xingcheng Biotechnology Alirocumab Product Portfolio
        6.7.5 Hubei Xingcheng Biotechnology Recent Developments/Updates
    6.8 Hubei Zhongshan Medical Technology
        6.8.1 Hubei Zhongshan Medical Technology Corporation Information
        6.8.2 Hubei Zhongshan Medical Technology Description and Business Overview
        6.8.3 Hubei Zhongshan Medical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Hubei Zhongshan Medical Technology Alirocumab Product Portfolio
        6.8.5 Hubei Zhongshan Medical Technology Recent Developments/Updates
    6.9 Jiangxi Ruiweier Biotechnology
        6.9.1 Jiangxi Ruiweier Biotechnology Corporation Information
        6.9.2 Jiangxi Ruiweier Biotechnology Description and Business Overview
        6.9.3 Jiangxi Ruiweier Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Jiangxi Ruiweier Biotechnology Alirocumab Product Portfolio
        6.9.5 Jiangxi Ruiweier Biotechnology Recent Developments/Updates
    6.10 Kailide Biomedical Technology
        6.10.1 Kailide Biomedical Technology Corporation Information
        6.10.2 Kailide Biomedical Technology Description and Business Overview
        6.10.3 Kailide Biomedical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Kailide Biomedical Technology Alirocumab Product Portfolio
        6.10.5 Kailide Biomedical Technology Recent Developments/Updates
    6.11 Nantong Feiyu Biological Technology
        6.11.1 Nantong Feiyu Biological Technology Corporation Information
        6.11.2 Nantong Feiyu Biological Technology Alirocumab Description and Business Overview
        6.11.3 Nantong Feiyu Biological Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Nantong Feiyu Biological Technology Alirocumab Product Portfolio
        6.11.5 Nantong Feiyu Biological Technology Recent Developments/Updates
    6.12 Nantong Hi-Future Biotechnology
        6.12.1 Nantong Hi-Future Biotechnology Corporation Information
        6.12.2 Nantong Hi-Future Biotechnology Alirocumab Description and Business Overview
        6.12.3 Nantong Hi-Future Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Nantong Hi-Future Biotechnology Alirocumab Product Portfolio
        6.12.5 Nantong Hi-Future Biotechnology Recent Developments/Updates
    6.13 Shanghai Baishikai Chemical Technology
        6.13.1 Shanghai Baishikai Chemical Technology Corporation Information
        6.13.2 Shanghai Baishikai Chemical Technology Alirocumab Description and Business Overview
        6.13.3 Shanghai Baishikai Chemical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Shanghai Baishikai Chemical Technology Alirocumab Product Portfolio
        6.13.5 Shanghai Baishikai Chemical Technology Recent Developments/Updates
    6.14 Shanghai Biochempartner
        6.14.1 Shanghai Biochempartner Corporation Information
        6.14.2 Shanghai Biochempartner Alirocumab Description and Business Overview
        6.14.3 Shanghai Biochempartner Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Shanghai Biochempartner Alirocumab Product Portfolio
        6.14.5 Shanghai Biochempartner Recent Developments/Updates
    6.15 Shanghai Loulan Biotechnology
        6.15.1 Shanghai Loulan Biotechnology Corporation Information
        6.15.2 Shanghai Loulan Biotechnology Alirocumab Description and Business Overview
        6.15.3 Shanghai Loulan Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Shanghai Loulan Biotechnology Alirocumab Product Portfolio
        6.15.5 Shanghai Loulan Biotechnology Recent Developments/Updates
    6.16 Shanghai Macklin Biochemical
        6.16.1 Shanghai Macklin Biochemical Corporation Information
        6.16.2 Shanghai Macklin Biochemical Alirocumab Description and Business Overview
        6.16.3 Shanghai Macklin Biochemical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Shanghai Macklin Biochemical Alirocumab Product Portfolio
        6.16.5 Shanghai Macklin Biochemical Recent Developments/Updates
    6.17 Shanghai Minkai Biotechnology
        6.17.1 Shanghai Minkai Biotechnology Corporation Information
        6.17.2 Shanghai Minkai Biotechnology Alirocumab Description and Business Overview
        6.17.3 Shanghai Minkai Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Shanghai Minkai Biotechnology Alirocumab Product Portfolio
        6.17.5 Shanghai Minkai Biotechnology Recent Developments/Updates
    6.18 Shanghai Ruihui Chemical Technology
        6.18.1 Shanghai Ruihui Chemical Technology Corporation Information
        6.18.2 Shanghai Ruihui Chemical Technology Alirocumab Description and Business Overview
        6.18.3 Shanghai Ruihui Chemical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Shanghai Ruihui Chemical Technology Alirocumab Product Portfolio
        6.18.5 Shanghai Ruihui Chemical Technology Recent Developments/Updates
    6.19 Shanghai Saimai Biotechnology
        6.19.1 Shanghai Saimai Biotechnology Corporation Information
        6.19.2 Shanghai Saimai Biotechnology Alirocumab Description and Business Overview
        6.19.3 Shanghai Saimai Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 Shanghai Saimai Biotechnology Alirocumab Product Portfolio
        6.19.5 Shanghai Saimai Biotechnology Recent Developments/Updates
    6.20 Shanghai Yifei Biotechnology
        6.20.1 Shanghai Yifei Biotechnology Corporation Information
        6.20.2 Shanghai Yifei Biotechnology Alirocumab Description and Business Overview
        6.20.3 Shanghai Yifei Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.20.4 Shanghai Yifei Biotechnology Alirocumab Product Portfolio
        6.20.5 Shanghai Yifei Biotechnology Recent Developments/Updates
    6.21 Sichuan Weiqi Biotechnology
        6.21.1 Sichuan Weiqi Biotechnology Corporation Information
        6.21.2 Sichuan Weiqi Biotechnology Alirocumab Description and Business Overview
        6.21.3 Sichuan Weiqi Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.21.4 Sichuan Weiqi Biotechnology Alirocumab Product Portfolio
        6.21.5 Sichuan Weiqi Biotechnology Recent Developments/Updates
    6.22 Taizhou KEDE Chemical
        6.22.1 Taizhou KEDE Chemical Corporation Information
        6.22.2 Taizhou KEDE Chemical Alirocumab Description and Business Overview
        6.22.3 Taizhou KEDE Chemical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.22.4 Taizhou KEDE Chemical Alirocumab Product Portfolio
        6.22.5 Taizhou KEDE Chemical Recent Developments/Updates
    6.23 Taizhou Kerui Bio-Technology
        6.23.1 Taizhou Kerui Bio-Technology Corporation Information
        6.23.2 Taizhou Kerui Bio-Technology Alirocumab Description and Business Overview
        6.23.3 Taizhou Kerui Bio-Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.23.4 Taizhou Kerui Bio-Technology Alirocumab Product Portfolio
        6.23.5 Taizhou Kerui Bio-Technology Recent Developments/Updates
    6.24 Tianmen Hengchang Chemical
        6.24.1 Tianmen Hengchang Chemical Corporation Information
        6.24.2 Tianmen Hengchang Chemical Alirocumab Description and Business Overview
        6.24.3 Tianmen Hengchang Chemical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.24.4 Tianmen Hengchang Chemical Alirocumab Product Portfolio
        6.24.5 Tianmen Hengchang Chemical Recent Developments/Updates
    6.25 WeiShi Reagent
        6.25.1 WeiShi Reagent Corporation Information
        6.25.2 WeiShi Reagent Alirocumab Description and Business Overview
        6.25.3 WeiShi Reagent Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.25.4 WeiShi Reagent Alirocumab Product Portfolio
        6.25.5 WeiShi Reagent Recent Developments/Updates
    6.26 Wuhan Dingxintong Pharmaceutical
        6.26.1 Wuhan Dingxintong Pharmaceutical Corporation Information
        6.26.2 Wuhan Dingxintong Pharmaceutical Alirocumab Description and Business Overview
        6.26.3 Wuhan Dingxintong Pharmaceutical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.26.4 Wuhan Dingxintong Pharmaceutical Alirocumab Product Portfolio
        6.26.5 Wuhan Dingxintong Pharmaceutical Recent Developments/Updates
    6.27 Wuhan Fortuna Chemical
        6.27.1 Wuhan Fortuna Chemical Corporation Information
        6.27.2 Wuhan Fortuna Chemical Alirocumab Description and Business Overview
        6.27.3 Wuhan Fortuna Chemical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.27.4 Wuhan Fortuna Chemical Alirocumab Product Portfolio
        6.27.5 Wuhan Fortuna Chemical Recent Developments/Updates
    6.28 Wuhan Sunrise Technology Development
        6.28.1 Wuhan Sunrise Technology Development Corporation Information
        6.28.2 Wuhan Sunrise Technology Development Alirocumab Description and Business Overview
        6.28.3 Wuhan Sunrise Technology Development Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.28.4 Wuhan Sunrise Technology Development Alirocumab Product Portfolio
        6.28.5 Wuhan Sunrise Technology Development Recent Developments/Updates
    6.29 Wuhan Weisman Bioengineering
        6.29.1 Wuhan Weisman Bioengineering Corporation Information
        6.29.2 Wuhan Weisman Bioengineering Alirocumab Description and Business Overview
        6.29.3 Wuhan Weisman Bioengineering Alirocumab Sales, Revenue and Gross Margin (2017-2022)
        6.29.4 Wuhan Weisman Bioengineering Alirocumab Product Portfolio
        6.29.5 Wuhan Weisman Bioengineering Recent Developments/Updates
7 Alirocumab Manufacturing Cost Analysis
    7.1 Alirocumab Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Alirocumab
    7.4 Alirocumab Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Alirocumab Distributors List
    8.3 Alirocumab Customers
9 Alirocumab Market Dynamics
    9.1 Alirocumab Industry Trends
    9.2 Alirocumab Market Drivers
    9.3 Alirocumab Market Challenges
    9.4 Alirocumab Market Restraints
10 Global Market Forecast
    10.1 Alirocumab Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Alirocumab by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Alirocumab by Type (2023-2028)
    10.2 Alirocumab Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Alirocumab by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Alirocumab by Application (2023-2028)
    10.3 Alirocumab Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Alirocumab by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Alirocumab by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Alirocumab Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
    Table 2. Global Alirocumab Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
    Table 3. Global Alirocumab Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Alirocumab Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Alirocumab Sales (Kg) of Key Manufacturers (2017-2022)
    Table 6. Global Alirocumab Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Alirocumab Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Alirocumab Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Alirocumab Average Price (US$/Kg) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Alirocumab Manufacturing Sites and Area Served
    Table 11. Manufacturers Alirocumab Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Alirocumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alirocumab as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Alirocumab Sales by Region (2017-2022) & (Kg)
    Table 16. Global Alirocumab Sales Market Share by Region (2017-2022)
    Table 17. Global Alirocumab Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Alirocumab Revenue Market Share by Region (2017-2022)
    Table 19. North America Alirocumab Sales by Country (2017-2022) & (Kg)
    Table 20. North America Alirocumab Sales Market Share by Country (2017-2022)
    Table 21. North America Alirocumab Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Alirocumab Revenue Market Share by Country (2017-2022)
    Table 23. Europe Alirocumab Sales by Country (2017-2022) & (Kg)
    Table 24. Europe Alirocumab Sales Market Share by Country (2017-2022)
    Table 25. Europe Alirocumab Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Alirocumab Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Alirocumab Sales by Region (2017-2022) & (Kg)
    Table 28. Asia Pacific Alirocumab Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Alirocumab Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Alirocumab Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Alirocumab Sales by Country (2017-2022) & (Kg)
    Table 32. Latin America Alirocumab Sales Market Share by Country (2017-2022)
    Table 33. Latin America Alirocumab Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Alirocumab Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Alirocumab Sales by Country (2017-2022) & (Kg)
    Table 36. Middle East and Africa Alirocumab Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Alirocumab Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Alirocumab Revenue Market Share by Country (2017-2022)
    Table 39. Global Alirocumab Sales by Type (2017-2022) & (Kg)
    Table 40. Global Alirocumab Sales Market Share by Type (2017-2022)
    Table 41. Global Alirocumab Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Alirocumab Revenue Share by Type (2017-2022)
    Table 43. Global Alirocumab Price by Type (2017-2022) & (US$/Kg)
    Table 44. Global Alirocumab Sales (Kg) by Application (2017-2022)
    Table 45. Global Alirocumab Sales Market Share by Application (2017-2022)
    Table 46. Global Alirocumab Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Alirocumab Revenue Share by Application (2017-2022)
    Table 48. Global Alirocumab Price by Application (2017-2022) & (US$/Kg)
    Table 49. AK Scientific Corporation Information
    Table 50. AK Scientific Description and Business Overview
    Table 51. AK Scientific Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 52. AK Scientific Alirocumab Product
    Table 53. AK Scientific Recent Developments/Updates
    Table 54. Carbosynth Corporation Information
    Table 55. Carbosynth Description and Business Overview
    Table 56. Carbosynth Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 57. Carbosynth Alirocumab Product
    Table 58. Carbosynth Recent Developments/Updates
    Table 59. TargetMol Chemicals Corporation Information
    Table 60. TargetMol Chemicals Description and Business Overview
    Table 61. TargetMol Chemicals Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 62. TargetMol Chemicals Alirocumab Product
    Table 63. TargetMol Chemicals Recent Developments/Updates
    Table 64. Beijing Aomi Jiade Pharmaceutical Technology Corporation Information
    Table 65. Beijing Aomi Jiade Pharmaceutical Technology Description and Business Overview
    Table 66. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 67. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product
    Table 68. Beijing Aomi Jiade Pharmaceutical Technology Recent Developments/Updates
    Table 69. Hefei Hirisun Pharmatech Corporation Information
    Table 70. Hefei Hirisun Pharmatech Description and Business Overview
    Table 71. Hefei Hirisun Pharmatech Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 72. Hefei Hirisun Pharmatech Alirocumab Product
    Table 73. Hefei Hirisun Pharmatech Recent Developments/Updates
    Table 74. Hubei Widely Chemical Technology Corporation Information
    Table 75. Hubei Widely Chemical Technology Description and Business Overview
    Table 76. Hubei Widely Chemical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 77. Hubei Widely Chemical Technology Alirocumab Product
    Table 78. Hubei Widely Chemical Technology Recent Developments/Updates
    Table 79. Hubei Xingcheng Biotechnology Corporation Information
    Table 80. Hubei Xingcheng Biotechnology Description and Business Overview
    Table 81. Hubei Xingcheng Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 82. Hubei Xingcheng Biotechnology Alirocumab Product
    Table 83. Hubei Xingcheng Biotechnology Recent Developments/Updates
    Table 84. Hubei Zhongshan Medical Technology Corporation Information
    Table 85. Hubei Zhongshan Medical Technology Description and Business Overview
    Table 86. Hubei Zhongshan Medical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 87. Hubei Zhongshan Medical Technology Alirocumab Product
    Table 88. Hubei Zhongshan Medical Technology Recent Developments/Updates
    Table 89. Jiangxi Ruiweier Biotechnology Corporation Information
    Table 90. Jiangxi Ruiweier Biotechnology Description and Business Overview
    Table 91. Jiangxi Ruiweier Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 92. Jiangxi Ruiweier Biotechnology Alirocumab Product
    Table 93. Jiangxi Ruiweier Biotechnology Recent Developments/Updates
    Table 94. Kailide Biomedical Technology Corporation Information
    Table 95. Kailide Biomedical Technology Description and Business Overview
    Table 96. Kailide Biomedical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 97. Kailide Biomedical Technology Alirocumab Product
    Table 98. Kailide Biomedical Technology Recent Developments/Updates
    Table 99. Nantong Feiyu Biological Technology Corporation Information
    Table 100. Nantong Feiyu Biological Technology Description and Business Overview
    Table 101. Nantong Feiyu Biological Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 102. Nantong Feiyu Biological Technology Alirocumab Product
    Table 103. Nantong Feiyu Biological Technology Recent Developments/Updates
    Table 104. Nantong Hi-Future Biotechnology Corporation Information
    Table 105. Nantong Hi-Future Biotechnology Description and Business Overview
    Table 106. Nantong Hi-Future Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 107. Nantong Hi-Future Biotechnology Alirocumab Product
    Table 108. Nantong Hi-Future Biotechnology Recent Developments/Updates
    Table 109. Shanghai Baishikai Chemical Technology Corporation Information
    Table 110. Shanghai Baishikai Chemical Technology Description and Business Overview
    Table 111. Shanghai Baishikai Chemical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 112. Shanghai Baishikai Chemical Technology Alirocumab Product
    Table 113. Shanghai Baishikai Chemical Technology Recent Developments/Updates
    Table 114. Shanghai Biochempartner Corporation Information
    Table 115. Shanghai Biochempartner Description and Business Overview
    Table 116. Shanghai Biochempartner Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 117. Shanghai Biochempartner Alirocumab Product
    Table 118. Shanghai Biochempartner Recent Developments/Updates
    Table 119. Shanghai Loulan Biotechnology Corporation Information
    Table 120. Shanghai Loulan Biotechnology Description and Business Overview
    Table 121. Shanghai Loulan Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 122. Shanghai Loulan Biotechnology Alirocumab Product
    Table 123. Shanghai Loulan Biotechnology Recent Developments/Updates
    Table 124. Shanghai Macklin Biochemical Corporation Information
    Table 125. Shanghai Macklin Biochemical Description and Business Overview
    Table 126. Shanghai Macklin Biochemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 127. Shanghai Macklin Biochemical Alirocumab Product
    Table 128. Shanghai Macklin Biochemical Recent Developments/Updates
    Table 129. Shanghai Minkai Biotechnology Corporation Information
    Table 130. Shanghai Minkai Biotechnology Description and Business Overview
    Table 131. Shanghai Minkai Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 132. Shanghai Minkai Biotechnology Alirocumab Product
    Table 133. Shanghai Minkai Biotechnology Recent Developments/Updates
    Table 134. Shanghai Ruihui Chemical Technology Corporation Information
    Table 135. Shanghai Ruihui Chemical Technology Description and Business Overview
    Table 136. Shanghai Ruihui Chemical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 137. Shanghai Ruihui Chemical Technology Alirocumab Product
    Table 138. Shanghai Ruihui Chemical Technology Recent Developments/Updates
    Table 139. Shanghai Saimai Biotechnology Corporation Information
    Table 140. Shanghai Saimai Biotechnology Description and Business Overview
    Table 141. Shanghai Saimai Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 142. Shanghai Saimai Biotechnology Alirocumab Product
    Table 143. Shanghai Saimai Biotechnology Recent Developments/Updates
    Table 144. Shanghai Yifei Biotechnology Corporation Information
    Table 145. Shanghai Yifei Biotechnology Description and Business Overview
    Table 146. Shanghai Yifei Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 147. Shanghai Yifei Biotechnology Alirocumab Product
    Table 148. Shanghai Yifei Biotechnology Recent Developments/Updates
    Table 149. Sichuan Weiqi Biotechnology Corporation Information
    Table 150. Sichuan Weiqi Biotechnology Description and Business Overview
    Table 151. Sichuan Weiqi Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 152. Sichuan Weiqi Biotechnology Alirocumab Product
    Table 153. Sichuan Weiqi Biotechnology Recent Developments/Updates
    Table 154. Taizhou KEDE Chemical Corporation Information
    Table 155. Taizhou KEDE Chemical Description and Business Overview
    Table 156. Taizhou KEDE Chemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 157. Taizhou KEDE Chemical Alirocumab Product
    Table 158. Taizhou KEDE Chemical Recent Developments/Updates
    Table 159. Taizhou Kerui Bio-Technology Corporation Information
    Table 160. Taizhou Kerui Bio-Technology Description and Business Overview
    Table 161. Taizhou Kerui Bio-Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 162. Taizhou Kerui Bio-Technology Alirocumab Product
    Table 163. Taizhou Kerui Bio-Technology Recent Developments/Updates
    Table 164. Tianmen Hengchang Chemical Corporation Information
    Table 165. Tianmen Hengchang Chemical Description and Business Overview
    Table 166. Tianmen Hengchang Chemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 167. Tianmen Hengchang Chemical Alirocumab Product
    Table 168. Tianmen Hengchang Chemical Recent Developments/Updates
    Table 169. WeiShi Reagent Corporation Information
    Table 170. WeiShi Reagent Description and Business Overview
    Table 171. WeiShi Reagent Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 172. WeiShi Reagent Alirocumab Product
    Table 173. WeiShi Reagent Recent Developments/Updates
    Table 174. Wuhan Dingxintong Pharmaceutical Corporation Information
    Table 175. Wuhan Dingxintong Pharmaceutical Description and Business Overview
    Table 176. Wuhan Dingxintong Pharmaceutical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 177. Wuhan Dingxintong Pharmaceutical Alirocumab Product
    Table 178. Wuhan Dingxintong Pharmaceutical Recent Developments/Updates
    Table 179. Wuhan Fortuna Chemical Corporation Information
    Table 180. Wuhan Fortuna Chemical Description and Business Overview
    Table 181. Wuhan Fortuna Chemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 182. Wuhan Fortuna Chemical Alirocumab Product
    Table 183. Wuhan Fortuna Chemical Recent Developments/Updates
    Table 184. Wuhan Sunrise Technology Development Corporation Information
    Table 185. Wuhan Sunrise Technology Development Description and Business Overview
    Table 186. Wuhan Sunrise Technology Development Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 187. Wuhan Sunrise Technology Development Alirocumab Product
    Table 188. Wuhan Sunrise Technology Development Recent Developments/Updates
    Table 189. Wuhan Weisman Bioengineering Corporation Information
    Table 190. Wuhan Weisman Bioengineering Description and Business Overview
    Table 191. Wuhan Weisman Bioengineering Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
    Table 192. Wuhan Weisman Bioengineering Alirocumab Product
    Table 193. Wuhan Weisman Bioengineering Recent Developments/Updates
    Table 194. Production Base and Market Concentration Rate of Raw Material
    Table 195. Key Suppliers of Raw Materials
    Table 196. Alirocumab Distributors List
    Table 197. Alirocumab Customers List
    Table 198. Alirocumab Market Trends
    Table 199. Alirocumab Market Drivers
    Table 200. Alirocumab Market Challenges
    Table 201. Alirocumab Market Restraints
    Table 202. Global Alirocumab Sales Forecast by Type (2023-2028) & (Kg)
    Table 203. Global Alirocumab Sales Market Share Forecast by Type (2023-2028)
    Table 204. Global Alirocumab Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 205. Global Alirocumab Revenue Market Share Forecast by Type (2023-2028)
    Table 206. Global Alirocumab Sales Forecast by Application (2023-2028) & (Kg)
    Table 207. Global Alirocumab Sales Market Share Forecast by Application (2023-2028)
    Table 208. Global Alirocumab Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 209. Global Alirocumab Revenue Market Share Forecast by Application (2023-2028)
    Table 210. Global Alirocumab Sales Forecast by Region (2023-2028) & (Kg)
    Table 211. Global Alirocumab Sales Market Share Forecast by Region (2023-2028)
    Table 212. Global Alirocumab Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 213. Global Alirocumab Revenue Market Share Forecast by Region (2023-2028)
    Table 214. Research Programs/Design for This Report
    Table 215. Key Data Information from Secondary Sources
    Table 216. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Alirocumab
    Figure 2. Global Alirocumab Market Share by Type in 2021 & 2028
    Figure 3. Patent Product Picture
    Figure 4. Generic Product Picture
    Figure 5. Global Alirocumab Market Share by Application in 2021 & 2028
    Figure 6. Biochemical Reagents
    Figure 7. Pharmaceutical Intermediates
    Figure 8. Global Alirocumab Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Alirocumab Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Alirocumab Sales (2017-2028) & (Kg)
    Figure 11. Alirocumab Sales Share by Manufacturers in 2021
    Figure 12. Global Alirocumab Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Alirocumab Players: Market Share by Revenue in 2021
    Figure 14. Alirocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Alirocumab Sales Market Share by Region (2017-2022)
    Figure 16. Global Alirocumab Sales Market Share by Region in 2021
    Figure 17. Global Alirocumab Revenue Market Share by Region (2017-2022)
    Figure 18. Global Alirocumab Revenue Market Share by Region in 2021
    Figure 19. United States Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. U.K. Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Alirocumab by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Alirocumab
    Figure 43. Manufacturing Process Analysis of Alirocumab
    Figure 44. Alirocumab Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AK Scientific
Carbosynth
TargetMol Chemicals
Beijing Aomi Jiade Pharmaceutical Technology
Hefei Hirisun Pharmatech
Hubei Widely Chemical Technology
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Jiangxi Ruiweier Biotechnology
Kailide Biomedical Technology
Nantong Feiyu Biological Technology
Nantong Hi-Future Biotechnology
Shanghai Baishikai Chemical Technology
Shanghai Biochempartner
Shanghai Loulan Biotechnology
Shanghai Macklin Biochemical
Shanghai Minkai Biotechnology
Shanghai Ruihui Chemical Technology
Shanghai Saimai Biotechnology
Shanghai Yifei Biotechnology
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
Taizhou Kerui Bio-Technology
Tianmen Hengchang Chemical
WeiShi Reagent
Wuhan Dingxintong Pharmaceutical
Wuhan Fortuna Chemical
Wuhan Sunrise Technology Development
Wuhan Weisman Bioengineering
Frequently Asked Questions
Alirocumab report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Alirocumab report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Alirocumab report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Alemtuzumab

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Evolocumab

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Matuzumab

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Afutuzumab

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More